Free shipping on all orders over $ 500

GW3965 hydrochloride

Cat. No. M1929

All AbMole products are for research use only, cannot be used for human consumption.

GW3965 hydrochloride Structure
Synonym:

GW3965 HCl

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 79  USD79 In stock
2mg USD 36  USD36 In stock
5mg USD 60  USD60 In stock
10mg USD 92  USD92 In stock
25mg USD 190  USD190 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GW3965 hydrochloride is an agonist for the liver X receptor (LXR), reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats. GW3965 acts as a full agonist of hLXRα and hLXRβ (EC50 values are 190 and 30 nM respectively) in cell-based reporter gene assays. It is orally active in mice. When screened against a panel of nuclear receptors, it cross-reacted with only the pregnane X receptor (PXR). GW3965 hydrochloride displays potent antiatherogenic activity in mouse models of atherosclerosis. GW3965 dosing blunted the vasopressor effect of Ang II, which was significantly different with the 0.3 and 3 microg kg(-1) doses. GW3965 decreased Ang II-mediated vasopressor responses coincident with a trend toward reduced ATR gene expression, suggesting that LXR agonists could affect vascular reactivity. Alternate studies suggest that GW3965 hydrochloride increases apoA-I protein levels in the central nervous system independent of ABCA1. Since ABCA1 is a major regulator of cholesterol and phospholipid metabolism, GW3965 hydrochloride is a useful tool to study these cellular functions.

Product Citations
Customer Product Validations & Biological Datas
Source Allergol Int (2015). Figure 2. GW3965
Method Western Blot
Cell Lines mice
Concentrations 1 μM
Incubation Time 1 h
Results We examined the effects of GW3965 on the IgEþAg- or LPS-induced protein expression of IL- 1a, IL-1b, IL-6, and TNF-a. Consistent with our microarray data, GW3965 significantly attenuated the protein expression of IL-1a and IL-1b, but not of IL-6 or TNF-a, in MCs stimulated by IgEþAg
Protocol (for reference only)
Cell Experiment
Cell lines RAW264.7 cells
Preparation method Cellular Internalization of LXR Agonist
RAW264.7 cells were seeded into 24-well plates at a density of 1 × 105 cells per well 24 hours prior to the experiment. NPs encapsulating a GW3965 concentration of 1 μM were then incubated with cells for the desired time points. Afterwards, the cells were washed with PBS, followed by trypsinization and centrifugation to remove excess trypsin-EDTA. Cells were then resuspended in PBS, and cellular uptake of NPs was assessed via flow cytometry (BD LSR II, BD Bioscience, San Jose, CA). Data were analyzed using BD FACSDiva software.
Concentrations 1 μM
Incubation time 2 h
Animal Experiment
Animal models atherosclerotic lesions in Ldlr−/− mice
Formulation saline
Dosages 10mg/kg
Administration i.p.
Chemical Information
Molecular Weight 618.51
Formula C33H31NO3ClF3.HCl
CAS Number 405911-17-3
Solubility (25°C) DMSO ≥90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Zhang XQ, et al. Adv Healthc Mater. Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis.

[2] Stukas S, et al. Biochim Biophys Acta. The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1.

[3] Leik CE, et al. Br J Pharmacol. GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats.

Related Liver X Receptor Products
T0901317

T0901317 is a potent and selective agonist for both LXRα and LXRβ with an EC50 of 20~50 nM. T0901317 activates FXR with an EC50 of 5 μM. T0901317 is RORα and RORγ dual inverse agonist with Ki values of 132 nM and 51 nM, respectively.

SR9243

SR9243 is a potent and selective LXR inverse agonist.

LXR-623

LXR-623 is a novel liver X-receptor(LXR) agonist with IC50 values of 179 nM and 24 nM for LXR-α and LXR-β, respectively. It is orally bioavailable and readily passes the blood-brain barrier.

GSK2033

GSK2033 is a potent LXR antagonist.

SR9238

SR9238 is a liver X receptor (LXR) inverse agonist with IC50s of 214 nM and 43 nM for LXRα and LXRβ, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: GW3965 hydrochloride, GW3965 HCl supplier, Liver X Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.